AstraZeneca, AZN
AstraZeneca falls Friday, still outperforms market
AstraZeneca PLC AZN shares inched down 0.05% to £109.82 Friday, on what proved to be an all-around dismal trading session for the stock market, with the FTSE 100 Index UKX falling 0.86% to 8,248.49. Supported by world-class markets data from Dow Jones and FactSet,
This complaint was first surfaced by Law.com Radar, ALM's source for immediate alerting on just-filed cases in state and federal courts. Law.com Radar now offers state court coverage nationwide. Sign ...
If you suffered losses exceeding $100,000 in AstraZeneca between between February 23, 2022 and December 17, 2024 and would ...
By Bhanvi Satija (Reuters) -Johnson & Johnson said on Tuesday its chemotherapy-free combination treatment showed a meaningful ...
IT worker can continue legal battle against pharmaceutical giant after judge rules that impact of skin condition makes him a ...
SAN DIEGO, CA / ACCESSWIRE / January 9, 2025 / Robbins LLP reminds investors that a class action was filed on behalf of all ...
Hosted on MSN4d
AstraZeneca Stock Down Almost 14% in 3 Months: Time to Sell?AstraZeneca AZN stock has declined 14% in the past three months. A lot of this price decline is due to ongoing investigations ...
Novo Nordisk (NYSE: NVO) and AstraZeneca (NASDAQ: AZN) are among the largest companies in the pharmaceutical industry. Both ...
AstraZeneca has been taking a wider role in Vietnam’s healthcare sector to help expand access to quality healthcare.
AstraZeneca India has laid off over 125 employees in its biopharmaceutical business unit, including senior managers and sales ...
AstraZeneca (AZN – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Sachin Jain from Bank ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback